KRT3 (Keratin, type II cytoskeletal 3) variants and mutations
KRT3 (also known as Keratin, type II cytoskeletal 3) is a human protein-coding gene encoding a keratin, type II cytoskeletal 3 protein. It pairs with keratin 12 to build the corneal epithelial intermediate-filament network and maintain corneal surface integrity. Dominant pathogenic variants cause Meesmann corneal dystrophy with epithelial microcysts and recurrent irritation. This analysis covers 1,094 KRT3 variants and mutations. Of these, 81% have computational variant effect predictions. Disease context includes corneal dystrophy, Meesmann, 2, Meesmann corneal dystrophy, and corneal dystrophy. Example KRT3 variants include S2G, S2N, and R3*.
Variant analysis overview
- Gene: KRT3
- Protein: Keratin, type II cytoskeletal 3
- UniProt accession: P12035
- Organism: Homo sapiens
- Variants analyzed: 1094
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 822 unspecified-consequence records; 96 synonymous variants; 127 missense variants; 9 stop-gained variants; 9 in-frame deletions; 19 frameshift variants; 9 in-frame insertions; 3 splice-region variants; 2 substitution
- Prediction scores: 885 variants have prediction scores (81% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: corneal dystrophy, Meesmann, 2, Meesmann corneal dystrophy, corneal dystrophy, corneal disorder, congenital hereditary endothelial dystrophy of cornea, Sjogren syndrome, hepatocellular carcinoma, esophageal adenocarcinoma, central nervous system cancer, keratoconus, esophageal squamous cell carcinoma, Barrett esophagus.
Protein structure and variant hotspots
- Protein features: 1 domains; 4 post-translational modification sites.
- Structural context: 417 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT3 variants
Examples include S2G, S2N, R3*, R3K, Q4*, Q4E, Q4K, A5V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2G (p.Ser2Gly), TOPMed rs1267285603, gnomAD rs1267285603, REVEL 0.28, CADD 21.50
- S2N (p.Ser2Asn), ExAC rs770789253, gnomAD rs770789253, REVEL 0.19, CADD 0.35
- R3* (p.Arg3Ter), NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; high impact.
- R3K (p.Arg3Lys), gnomAD rs1322781302
- Q4* (p.Gln4Ter), ExAC rs746898698, gnomAD rs746898698, CADD 37.00
- Q4E (p.Gln4Glu), ExAC rs746898698, gnomAD rs746898698, REVEL 0.46, CADD 22.80
- Q4K (p.Gln4Lys), ExAC rs746898698, gnomAD rs746898698, REVEL 0.34, CADD 23.00
- A5V (p.Ala5Val), gnomAD rs1222118268, REVEL 0.10, CADD 0.43, Likely benign, not specified
- S9F (p.Ser9Phe), rs143951674, ClinGen CA6588327, ClinVar RCV004242447, 1000Genomes rs143951674, REVEL 0.09, CADD 13.80, Uncertain significance, not specified
- G12A (p.Gly12Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G12R (p.Gly12Arg), 1000Genomes rs546706676, ExAC rs546706676, TOPMed rs546706676, gnomAD rs546706676, REVEL 0.08, CADD 8.58, Uncertain significance, not specified
- S13N (p.Ser13Asn), TOPMed rs1182160925, gnomAD rs1182160925, REVEL 0.17, CADD 10.30
- S13R (p.Ser13Arg), rs201738438, ClinGen CA6588323, ClinVar RCV004281790, ESP rs201738438, REVEL 0.15, CADD 15.90, Uncertain significance, not specified
- G15V (p.Gly15Val), Ensembl rs1939640226
- F16S (p.Phe16Ser), ExAC rs753904849, gnomAD rs753904849, REVEL 0.40, CADD 21.10
- S17F (p.Ser17Phe), NCI-TCGA Cosmic COSV5881, REVEL 0.58, CADD 20.70, Variant assessed as somatic; moderate impact.
- S17P (p.Ser17Pro), ExAC rs766412120, TOPMed rs766412120, gnomAD rs766412120, REVEL 0.55, CADD 23.80
- G18S (p.Gly18Ser), rs750889026, NCI-TCGA Cosmic COSV5881, ExAC rs750889026, TOPMed rs750889026, REVEL 0.19, CADD 9.02, Variant assessed as somatic; moderate impact.
- R19C (p.Arg19Cys), rs570472655, NCI-TCGA Cosmic COSV5881, 1000Genomes rs570472655, ExAC rs570472655, REVEL 0.09, CADD 7.95, Uncertain significance
- R19G (p.Arg19Gly), rs570472655, ClinGen CA6588318, ClinVar RCV004111822, 1000Genomes rs570472655, REVEL 0.06, CADD 5.45, Uncertain significance, not specified
- R19H (p.Arg19His), rs376108603, ClinGen CA6588316, ClinVar RCV003551254, ClinVar RCV004636765, REVEL 0.08, CADD 9.38, Uncertain significance, not specified; not provided
- A21D (p.Ala21Asp), TOPMed rs1288985778, REVEL 0.42, CADD 23.70
- A21T (p.Ala21Thr), TOPMed rs933468180, REVEL 0.37, CADD 19.80
- V22A (p.Val22Ala), TOPMed rs1193249230, gnomAD rs1193249230, REVEL 0.23, CADD 14.40
- V22L (p.Val22Leu), TOPMed rs1375171912
- V23D (p.Val23Asp), Ensembl rs1565679906, REVEL 0.27, CADD 18.30
- S24C (p.Ser24Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G25C (p.Gly25Cys), ExAC rs750421344, TOPMed rs750421344, gnomAD rs750421344
- G25D (p.Gly25Asp), rs1466295880, NCI-TCGA Cosmic COSV1005, TOPMed rs1466295880, gnomAD rs1466295880, REVEL 0.30, CADD 22.00, Variant assessed as somatic; moderate impact.
- G25S (p.Gly25Ser), rs750421344, NCI-TCGA Cosmic COSV5881, ExAC rs750421344, TOPMed rs750421344, REVEL 0.22, CADD 6.72, Variant assessed as somatic; moderate impact.
- S26N (p.Ser26Asn), Ensembl rs1939638662
- S27R (p.Ser27Arg), ExAC rs770436470, gnomAD rs770436470, REVEL 0.32, CADD 20.40
- M29T (p.Met29Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S30N (p.Ser30Asn), Ensembl rs892240804, REVEL 0.35, CADD 18.30
- C31R (p.Cys31Arg), ExAC rs746942788, gnomAD rs746942788, REVEL 0.22, CADD 3.23
- C31Y (p.Cys31Tyr), rs777747344, ExAC rs777747344, TOPMed rs777747344, gnomAD rs777747344, AlphaMissense 0.14, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- V32A (p.Val32Ala), ExAC rs779168086, gnomAD rs779168086, REVEL 0.28, CADD 9.69
- V32E (p.Val32Glu), ExAC rs779168086, gnomAD rs779168086, REVEL 0.51, CADD 20.20
- V32L (p.Val32Leu), ExAC rs747935399, gnomAD rs747935399, REVEL 0.24, CADD 4.36
- A33G (p.Ala33Gly), TOPMed rs1268330924, gnomAD rs1268330924
- A33S (p.Ala33Ser), gnomAD rs1939637945, REVEL 0.21, CADD 6.05
- A33T (p.Ala33Thr), NCI-TCGA Cosmic COSV5881, REVEL 0.22, CADD 7.89, Variant assessed as somatic; moderate impact.
- A33V (p.Ala33Val), TOPMed rs1268330924, gnomAD rs1268330924, REVEL 0.38, CADD 19.70, Uncertain significance, not specified
- H34L (p.His34Leu), gnomAD rs1437272363, REVEL 0.16, CADD 1.48
- H34R (p.His34Arg), gnomAD rs1437272363, REVEL 0.17, CADD 1.14
- S35F (p.Ser35Phe), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; moderate impact.
- S35T (p.Ser35Thr), gnomAD rs1301994725, REVEL 0.17, CADD 0.05
- S35Y (p.Ser35Tyr), rs1389289222, NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5881, REVEL 0.39, CADD 12.00, Variant assessed as somatic; moderate impact.
- G36A (p.Gly36Ala), gnomAD rs1939637467, REVEL 0.19, CADD 3.33
- G36R (p.Gly36Arg), Ensembl rs1565679874, REVEL 0.16, CADD 0.83
- G37E (p.Gly37Glu), Ensembl rs2121226851, REVEL 0.39, CADD 7.96
- G37R (p.Gly37Arg), Ensembl rs267603529
- A38G (p.Ala38Gly), ESP rs374910086, ExAC rs374910086, TOPMed rs374910086, gnomAD rs374910086, REVEL 0.11, CADD 5.35
- A38T (p.Ala38Thr), Ensembl rs903704375, REVEL 0.18, CADD 6.03
- G39D (p.Gly39Asp), ExAC rs780016039, gnomAD rs780016039, REVEL 0.32, CADD 14.10
- G39S (p.Gly39Ser), 1000Genomes rs202180550, ExAC rs202180550, gnomAD rs202180550, REVEL 0.20, CADD 0.06
- G40* (p.Gly40Ter), 1000Genomes rs199902669, ESP rs199902669, ExAC rs199902669, TOPMed rs199902669, CADD 33.00
- G40A (p.Gly40Ala), TOPMed rs928474636, REVEL 0.40, CADD 11.50
- G40R (p.Gly40Arg), 1000Genomes rs199902669, ESP rs199902669, ExAC rs199902669, TOPMed rs199902669, REVEL 0.27, CADD 14.70
- A42P (p.Ala42Pro), ExAC rs768064246, gnomAD rs768064246, Uncertain significance
- A42T (p.Ala42Thr), ExAC rs768064246, gnomAD rs768064246, REVEL 0.20, CADD 13.50, Uncertain significance, not specified
- A42V (p.Ala42Val), TOPMed rs1187076781, gnomAD rs1187076781, REVEL 0.14, CADD 12.00
- Y43C (p.Tyr43Cys), 1000Genomes rs200847081, ESP rs200847081, ExAC rs200847081, TOPMed rs200847081, REVEL 0.19, CADD 0.04
- G44A (p.Gly44Ala), rs28721426, ClinGen CA6588297, ClinVar RCV002173527, UniProt VAR 061297, REVEL 0.26, CADD 16.30, Benign, not provided
- G44S (p.Gly44Ser), ExAC rs751984274, gnomAD rs751984274, REVEL 0.30, CADD 14.10
- G44T (p.Gly44Thr), rs1939636114, ClinGen CA2036681093, ClinVar RCV001293776, Ensembl rs1939636114, Uncertain significance, Congenital hereditary endothelial dystrophy of cornea
- F45V (p.Phe45Val), ExAC rs776298144, TOPMed rs776298144, gnomAD rs776298144, REVEL 0.20, CADD 0.02
- R46Q (p.Arg46Gln), ExAC rs774042565, TOPMed rs774042565, gnomAD rs774042565, REVEL 0.28, CADD 0.60
- R46W (p.Arg46Trp), rs368389807, ClinGen CA6588294, ClinVar RCV003575892, ClinVar RCV004369320, REVEL 0.27, CADD 12.90, Conflicting interpretations, not provided; not specified
- S47R (p.Ser47Arg), 1000Genomes rs372128289, ESP rs372128289, ExAC rs372128289, TOPMed rs372128289, REVEL 0.44, CADD 0.00
- G48R (p.Gly48Arg), rs370673258, ESP rs370673258, ExAC rs370673258, TOPMed rs370673258, REVEL 0.38, CADD 16.00, Variant assessed as somatic; moderate impact.
- A49E (p.Ala49Glu), ExAC rs774159481, gnomAD rs774159481, REVEL 0.31, CADD 6.21
- A49T (p.Ala49Thr), gnomAD rs1380786929, REVEL 0.17, CADD 9.46
- G50C (p.Gly50Cys), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- G50V (p.Gly50Val), TOPMed rs1939635125
- G51S (p.Gly51Ser), gnomAD rs1352416793, REVEL 0.15, CADD 11.10
- R55C (p.Arg55Cys), ExAC rs768388285, TOPMed rs768388285, gnomAD rs768388285, REVEL 0.40, CADD 22.80
- R55H (p.Arg55His), ExAC rs749517076, TOPMed rs749517076, gnomAD rs749517076, REVEL 0.25, CADD 17.10, Uncertain significance, not specified
- R55L (p.Arg55Leu), ExAC rs749517076, TOPMed rs749517076, gnomAD rs749517076
- S56N (p.Ser56Asn), Ensembl rs1939634592
- S56R (p.Ser56Arg), ExAC rs780288321, TOPMed rs780288321, gnomAD rs780288321, REVEL 0.55, CADD 23.80
- Y58C (p.Tyr58Cys), TOPMed rs1422118288, gnomAD rs1422118288, REVEL 0.50, CADD 24.70
- L60M (p.Leu60Met), Ensembl rs1565679806, REVEL 0.37, CADD 21.90
- G61D (p.Gly61Asp), ExAC rs756214553, TOPMed rs756214553, gnomAD rs756214553, REVEL 0.64, CADD 24.50
- G61S (p.Gly61Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G62R (p.Gly62Arg), ExAC rs781360634, TOPMed rs781360634, gnomAD rs781360634, Uncertain significance
- G62S (p.Gly62Ser), rs781360634, ClinGen CA6588282, ClinVar RCV004412302, ExAC rs781360634, REVEL 0.36, CADD 18.10, Uncertain significance, not specified
- N63K (p.Asn63Lys), gnomAD rs1206975306, REVEL 0.27, CADD 14.60
- K64N (p.Lys64Asn), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- S65I (p.Ser65Ile), NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; moderate impact.
- S65N (p.Ser65Asn), NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; moderate impact.
- I66F (p.Ile66Phe), 1000Genomes rs2121226557, REVEL 0.48, CADD 23.60
- S67T (p.Ser67Thr), TOPMed rs1939633323, gnomAD rs1939633323, REVEL 0.42, CADD 22.30
- I68N (p.Ile68Asn), 1000Genomes rs201564104, TOPMed rs201564104, gnomAD rs201564104, REVEL 0.31, CADD 16.40
- I68S (p.Ile68Ser), 1000Genomes rs201564104, TOPMed rs201564104, gnomAD rs201564104, REVEL 0.18, CADD 16.20
- S69G (p.Ser69Gly), ExAC rs752074039, TOPMed rs752074039, gnomAD rs752074039, REVEL 0.20, CADD 13.10
- S69I (p.Ser69Ile), 1000Genomes rs199517745, ExAC rs199517745, TOPMed rs199517745, gnomAD rs199517745, REVEL 0.36, CADD 22.20
- S69N (p.Ser69Asn), 1000Genomes rs199517745, ExAC rs199517745, TOPMed rs199517745, gnomAD rs199517745, REVEL 0.26, CADD 15.90
- V70L (p.Val70Leu), 1000Genomes rs150657845, ESP rs150657845, ExAC rs150657845, TOPMed rs150657845, REVEL 0.33, CADD 12.00, Uncertain significance, not specified
- V70M (p.Val70Met), rs150657845, ClinGen CA6588277, ClinVar RCV003696856, 1000Genomes rs150657845, REVEL 0.21, CADD 12.40, Benign, not provided
- A71E (p.Ala71Glu), TOPMed rs1312740727, gnomAD rs1312740727
- A71V (p.Ala71Val), TOPMed rs1312740727, gnomAD rs1312740727
- A72S (p.Ala72Ser), NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; moderate impact.
- A72V (p.Ala72Val), Ensembl rs1939632604
- G74C (p.Gly74Cys), rs557308178, NCI-TCGA Cosmic COSV5881, 1000Genomes rs557308178, ExAC rs557308178, REVEL 0.21, CADD 16.10, Uncertain significance
- G74S (p.Gly74Ser), rs557308178, ClinGen CA6588273, ClinVar RCV004341396, 1000Genomes rs557308178, REVEL 0.20, CADD 7.24, Uncertain significance, not specified
- G74V (p.Gly74Val), rs1939632095, ClinGen CA384979509, ClinVar RCV004147914, gnomAD rs1939632095, REVEL 0.51, CADD 21.00, Uncertain significance, not specified
- S75F (p.Ser75Phe), rs761759347, NCI-TCGA Cosmic COSV1005, 1000Genomes rs761759347, ExAC rs761759347, REVEL 0.30, CADD 15.80, Variant assessed as somatic; moderate impact.
- R76G (p.Arg76Gly), ExAC rs762235173, TOPMed rs762235173, gnomAD rs762235173, REVEL 0.21, CADD 8.94, Uncertain significance
- R76L (p.Arg76Leu), 1000Genomes rs201539577, ESP rs201539577, ExAC rs201539577, TOPMed rs201539577
- R76P (p.Arg76Pro), 1000Genomes rs201539577, ESP rs201539577, ExAC rs201539577, TOPMed rs201539577, REVEL 0.44, CADD 16.20, Uncertain significance, not specified
- R76Q (p.Arg76Gln), 1000Genomes rs201539577, ESP rs201539577, ExAC rs201539577, TOPMed rs201539577, REVEL 0.10, CADD 11.60, Benign, not provided
- R76W (p.Arg76Trp), rs762235173, ClinGen CA6588271, ClinVar RCV004259465, ClinVar RCV006473967, REVEL 0.18, CADD 16.10, Conflicting interpretations, not specified; not provided
- A77V (p.Ala77Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G79C (p.Gly79Cys), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- G79R (p.Gly79Arg), gnomAD rs1400103770, REVEL 0.50, CADD 17.20
- G81A (p.Gly81Ala), 1000Genomes rs552886568, ExAC rs552886568, TOPMed rs552886568, gnomAD rs552886568, REVEL 0.52, CADD 17.50
- G81R (p.Gly81Arg), ExAC rs749103210, TOPMed rs749103210, gnomAD rs749103210, REVEL 0.51, CADD 20.70
- G81V (p.Gly81Val), 1000Genomes rs552886568, ExAC rs552886568, TOPMed rs552886568, gnomAD rs552886568, REVEL 0.64, CADD 22.10
- G82E (p.Gly82Glu), TOPMed rs1939630290, gnomAD rs1939630290, REVEL 0.49, CADD 16.90
- G82R (p.Gly82Arg), gnomAD rs1165507341, REVEL 0.41, CADD 14.80
- G83R (p.Gly83Arg), TOPMed rs1324645928, gnomAD rs1324645928, REVEL 0.52, CADD 17.90
- R84G (p.Arg84Gly), 1000Genomes rs62617086, ESP rs62617086, ExAC rs62617086, TOPMed rs62617086, REVEL 0.28, CADD 8.02, Benign
- R84Q (p.Arg84Gln), rs757365353, NCI-TCGA Cosmic COSV5881, ExAC rs757365353, TOPMed rs757365353, REVEL 0.11, CADD 7.38, Uncertain significance, not specified; not provided
- R84W (p.Arg84Trp), rs62617086, ClinGen CA6588263, ClinVar RCV000969625, ClinVar RCV003936084, REVEL 0.27, CADD 16.60, Benign/Likely benign, not provided
- S85N (p.Ser85Asn), 1000Genomes rs200265010, ExAC rs200265010, gnomAD rs200265010, REVEL 0.17, CADD 8.15
- S85R (p.Ser85Arg), ExAC rs778394515, TOPMed rs778394515, gnomAD rs778394515, REVEL 0.13, CADD 7.50
- S86G (p.Ser86Gly), ExAC rs758760315, gnomAD rs758760315, REVEL 0.04, CADD 3.87
- S86R (p.Ser86Arg), TOPMed rs1243912523, gnomAD rs1243912523, REVEL 0.17, CADD 0.94
- S86T (p.Ser86Thr), Ensembl rs777324417
- A88D (p.Ala88Asp), rs200393349, ClinGen CA384979348, ClinVar RCV004117667, AlphaMissense 0.05, MetaLR 0.29, Uncertain significance, not specified
- A88G (p.Ala88Gly), rs200393349, 1000Genomes rs200393349, ExAC rs200393349, TOPMed rs200393349, REVEL 0.07, AlphaMissense 0.05, Variant assessed as somatic; moderate impact.
- A90E (p.Ala90Glu), TOPMed rs1939629233, REVEL 0.13, CADD 1.21
- G91S (p.Gly91Ser), NCI-TCGA Cosmic COSV5881, REVEL 0.23, CADD 11.90, Variant assessed as somatic; moderate impact.
- G92C (p.Gly92Cys), NCI-TCGA TCGA novel, REVEL 0.45, CADD 17.30, Variant assessed as somatic; moderate impact.
- Y93H (p.Tyr93His), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- G94* (p.Gly94Ter), Ensembl rs938728905, CADD 33.00
- G94R (p.Gly94Arg), NCI-TCGA Cosmic COSV5881, Variant assessed as somatic; moderate impact.
- G95C (p.Gly95Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G95D (p.Gly95Asp), gnomAD rs1228698959, REVEL 0.45, CADD 16.50
- G95S (p.Gly95Ser), rs749992146, ClinGen CA6588255, ClinVar RCV004255923, ExAC rs749992146, REVEL 0.17, CADD 1.46, Likely benign, not specified
- G96S (p.Gly96Ser), ExAC rs767061040, TOPMed rs767061040, gnomAD rs767061040, REVEL 0.39, CADD 15.00
- F97C (p.Phe97Cys), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- F97L (p.Phe97Leu), ExAC rs751561509, TOPMed rs751561509, gnomAD rs751561509, REVEL 0.23, CADD 15.30
- G98R (p.Gly98Arg), ESP rs370707520, ExAC rs370707520, TOPMed rs370707520, gnomAD rs370707520, REVEL 0.36, CADD 16.70, Uncertain significance, not specified
- G98W (p.Gly98Trp), ESP rs370707520, ExAC rs370707520, TOPMed rs370707520, gnomAD rs370707520, REVEL 0.45, CADD 23.50, Uncertain significance, not specified
- S99R (p.Ser99Arg), 1000Genomes rs148001170, ExAC rs148001170, TOPMed rs148001170, gnomAD rs148001170, REVEL 0.21, CADD 0.04
- G100S (p.Gly100Ser), 1000Genomes rs188384912, ESP rs188384912, ExAC rs188384912, TOPMed rs188384912, REVEL 0.22, CADD 10.80, Conflicting interpretations, not provided; not specified
- G100V (p.Gly100Val), TOPMed rs1939627522
- Y101* (p.Tyr101Ter), ESP rs376089191, TOPMed rs376089191
- G102* (p.Gly102Ter), gnomAD rs1409941311
- G103A (p.Gly103Ala), Ensembl rs112593469
- G103C (p.Gly103Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G104D (p.Gly104Asp), TOPMed rs1328783622, REVEL 0.57, CADD 18.60
- F105L (p.Phe105Leu), 1000Genomes rs111435734, ESP rs111435734, ExAC rs111435734, TOPMed rs111435734, Benign
- G106D (p.Gly106Asp), ExAC rs759827934, TOPMed rs759827934, gnomAD rs759827934, REVEL 0.57, CADD 22.50
- G107A (p.Gly107Ala), gnomAD rs1939626240, REVEL 0.33, CADD 14.80
- G108S (p.Gly108Ser), TOPMed rs963482388, gnomAD rs963482388, REVEL 0.31, CADD 12.80, Uncertain significance, not specified
- G110C (p.Gly110Cys), ExAC rs776973006, TOPMed rs776973006, REVEL 0.51, CADD 23.20
- G111C (p.Gly111Cys), Ensembl rs1286830783
- G111D (p.Gly111Asp), ExAC rs771174913, TOPMed rs771174913, gnomAD rs771174913, REVEL 0.42, CADD 22.80, Uncertain significance, Corneal dystrophy, Meesmann, 2; not provided
- G112D (p.Gly112Asp), gnomAD rs1269405940, REVEL 0.35, CADD 14.70, Uncertain significance, not specified
- R113S (p.Arg113Ser), Ensembl rs2121226129
- M115I (p.Met115Ile), ExAC rs747082128, TOPMed rs747082128, gnomAD rs747082128, REVEL 0.18, CADD 3.33
- G116R (p.Gly116Arg), TOPMed rs1939625025, gnomAD rs1939625025, REVEL 0.34, CADD 19.50
- G117D (p.Gly117Asp), gnomAD rs1939624937, REVEL 0.47, CADD 18.00
- G120A (p.Gly120Ala), Ensembl rs1939624728
- G121R (p.Gly121Arg), ESP rs369751855, TOPMed rs369751855
- A122V (p.Ala122Val), TOPMed rs1481363664, gnomAD rs1481363664, REVEL 0.30, CADD 16.50
- G123A (p.Gly123Ala), TOPMed rs1939624160
- G124D (p.Gly124Asp), gnomAD rs1302586382, REVEL 0.56, CADD 22.90
- G127R (p.Gly127Arg), Ensembl rs1939623835
- A128P (p.Ala128Pro), gnomAD rs1387109524
- A128T (p.Ala128Thr), gnomAD rs1387109524, REVEL 0.08, CADD 8.63
- G129C (p.Gly129Cys), TOPMed rs1939623572, REVEL 0.46, CADD 22.50
- G130D (p.Gly130Asp), gnomAD rs1939623348, REVEL 0.58, CADD 21.90, Uncertain significance, not specified
- G130S (p.Gly130Ser), gnomAD rs1329373186, REVEL 0.34, CADD 18.90
- F131Y (p.Phe131Tyr), gnomAD rs1457866922, REVEL 0.45, CADD 13.00
- G133E (p.Gly133Glu), ExAC rs748539153, TOPMed rs748539153, gnomAD rs748539153, REVEL 0.37, CADD 17.90, Uncertain significance, Corneal dystrophy, Meesmann, 2
- G133R (p.Gly133Arg), ExAC rs772649423, gnomAD rs772649423, REVEL 0.40, CADD 18.10
Public KRT3 analysis runs
- KRT3 analysis run — KRT3 (1,094 variants) — completed 2026-08-22